Back
Verona Pharma PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Buy
55
VRNA
Verona Pharma PLC
Last Price:
38.79
Seasonality Move:
21.13%
Sell
22
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.66
Seasonality Move:
53.66%
Buy
55
Verona Pharma PLC (VRNA)
is a Buy
Is Verona Pharma PLC a Buy, Sell or Hold?
- The current Verona Pharma PLC [VRNA] share price is $38.81. The Score for VRNA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- VRNA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
22
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRNA Stock Price Chart
What is Verona Pharma PLC's stock price today?
-
The Verona Pharma PLC share price today is $38.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRNA is experiencing slight buying pressure.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.28 | Buy |
Relative Strength Index (14 RSI): | 60.84 | Buy |
Chaikin Money Flow: | 333544 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.33 - 38.41) | Buy |
Bollinger Bands (100): | (22.71 - 34.71) | Buy |
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 39.76 | Sell |
Chaikin Money Flow: | 1207506 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.66 - 0.82) | Sell |
Bollinger Bands (100): | (0.8 - 1.2) | Sell |
VRNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.07 | Buy |
20-day SMA: | 36.81 | Buy |
50-day SMA: | 33.54 | Buy |
200-day SMA: | 22.01 | Buy |
8-day EMA: | 37.71 | Buy |
20-day EMA: | 36.7 | Buy |
50-day EMA: | 33.73 | Buy |
200-day EMA: | 24.99 | Buy |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.65 | Buy |
20-day SMA: | 0.73 | Sell |
50-day SMA: | 0.84 | Sell |
200-day SMA: | 1.11 | Sell |
8-day EMA: | 0.67 | Sell |
20-day EMA: | 0.72 | Sell |
50-day EMA: | 0.83 | Sell |
200-day EMA: | 0.99 | Sell |
Verona Pharma PLC Earnings Growth & VRNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.73 per share, and an increase next year of $1.40 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.
Verona Pharma PLC Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Adaptimmune Therapeutics PLC Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |